Small molecule plasmodium FKBP35 inhibitor as a potential antimalaria agent

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Harikishore, Amaravadhi ^a   Niang, Makhtar ^a,b   Rajan, Sreekanth ^a   Preiser, Peter Rainer ^a   Yoon, Ho Sup ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; FK 506 BINDING PROTEIN; PROTEIN BINDING; PROTOZOAL PROTEIN;

AMINO ACID SEQUENCE; ANTAGONISTS AND INHIBITORS; BINDING SITE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FEASIBILITY STUDY; METABOLISM; MOLECULAR GENETICS; PLASMODIUM FALCIPARUM; SEQUENCE ANALYSIS; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANTIMALARIALS; BINDING SITES; CELL SURVIVAL; FEASIBILITY STUDIES; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEIN BINDING; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, PROTEIN; TACROLIMUS BINDING PROTEINS;

EID: 84883264897     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02501     Document Type: Article

References (65)

1. Gardner, M. J. et al.Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498-511 (2002).
2. Monaghan, P., Fardis, M., Revill, W. P. & Bell, A. Antimalarial effects of macrolactones related to FK520 (ascomycin) are independent of the immunosuppressive properties of the compounds. J Infect Dis 191, 1342-9 (2005).
3. Dondorp, A. M. et al. The Threat of Artemisinin-ResistantMalaria. New England Journal of Medicine 365, 1073-1075 (2011).
4. Bell, A.,Wernli, B. & Franklin, R. M. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. Biochem Pharmacol 48, 495-503 (1994). (Pubitemid 24257012)
5. Braun, P. D. et al. A bifunctional molecule that displays context-dependent cellular activity. J Am Chem Soc 125, 7575-80 (2003). (Pubitemid 36750278)
6. Kang, C. B., Ye, H., Yoon, H. R. & Yoon,H. S. Solution structure of FK506 binding domain (FKBD) of Plasmodium falciparum FK506 binding protein 35 (PfFKBP35). Proteins 70, 300-2 (2008). (Pubitemid 350293473)
7. Kumar, R., Adams, B., Musiyenko, A., Shulyayeva, O. & Barik, S. The FK506-binding protein of the malaria parasite, Plasmodium falciparum, is a FK506-sensitive chaperone with FK506-independent calcineurin-inhibitory activity. Mol Biochem Parasitol 141, 163-73 (2005). (Pubitemid 40591560)
8. Monaghan, P. & Bell, A. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities. Mol Biochem Parasitol 139, 185-95 (2005). (Pubitemid 40128214)
9. Barth, S. et al. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability. Mol Cell Biol 27, 3758-68 (2007). (Pubitemid 46726183)
10. Choi, B. H., Feng, L.&Yoon, H. S. FKBP38 protects Bcl-2 from caspase-dependent degradation. J Biol Chem 285, 9770-9 (2010).
11. Jinwal, U. K. et al. The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules. J Neurosci 30, 591-9 (2010).
12. Kuzuhara, T. & Horikoshi, M. A nuclear FK506-binding protein is a histone chaperone regulating rDNA silencing. Nat Struct Mol Biol 11, 275-83 (2004). (Pubitemid 38282774)
13. Nelson, C. J., Santos-Rosa, H. & Kouzarides, T. Proline isomerization of histone H3 regulates lysine methylation and gene expression. Cell 126, 905-16 (2006). (Pubitemid 44310777)
14. Cameron, A. M. et al. Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc Natl Acad Sci USA 92, 1784-8 (1995).
15. Riggs, D. L. et al. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J 22, 1158-67 (2003). (Pubitemid 36313599)
16. Wang, T. et al. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell 86, 435-44 (1996). (Pubitemid 26272083)
17. Ahearn, I. M. et al. FKBP12 binds to acylated H-ras and promotes depalmitoylation. Mol Cell 41, 173-85 (2011).
18. Shirane,M. & Nakayama, K. I. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol 5, 28-37 (2003). (Pubitemid 36054326)
19. Ochocka, A. M. et al. FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53. FEBS Lett 583, 621-6 (2009).
20. Yang, W. M., Inouye, C. J. & Seto, E. Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity. J Biol Chem 270, 15187-93 (1995).
21. Jayaraman, T. et al. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J Biol Chem 267, 9474-7 (1992).
22. Crackower, M. A. et al. Essential role of Fkbp6 in male fertility and homologous chromosome pairing in meiosis. Science 300, 1291-5 (2003). (Pubitemid 36618240)
23. Edlich, F. et al. The specific FKBP38 inhibitor N-(N',N'- dimethylcarboxamidomethyl) cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia. J Biol Chem 281, 14961-70 (2006). (Pubitemid 43855200)
24. Kotaka, M. et al. Crystal structure of the FK506 binding domain of Plasmodium falciparum FKBP35 in complex with FK506. Biochemistry 47, 5951-61 (2008). (Pubitemid 351770025)
25. Galat, A. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions. Curr Top Med Chem 3, 1315-47 (2003).
26. Alag, R. et al. NMR and crystallographic structures of the FK506 binding domain of human malarial parasite Plasmodium vivax FKBP35. Protein Sci 19, 1577-86 (2010).
27. Alag, R., Shin, J. & Yoon, H. S.NMRassignments of the FK506-binding domain of FK506-binding protein 35 from Plasmodium vivax. Biomol NMR Assign 3, 243-5 (2009).
28. Van Duyne, G. D., Standaert, R. F., Karplus, P. A., Schreiber, S. L. & Clardy, J. Atomic structure of FKBP-FK506, an immunophilin- immunosuppressant complex. Science 252, 839-42 (1991). (Pubitemid 121000524)
29. Van Duyne, G. D., Standaert, R. F., Karplus, P. A., Schreiber, S. L. & Clardy, J. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J Mol Biol 229, 105-24 (1993). (Pubitemid 23037917)
30. Mukai, H. et al. FKBP12-FK506 complex inhibits phosphatase activity of two mammalian isoforms of calcineurin irrespective of their substrates or activation mechanisms. J Biochem 113, 292-8 (1993). (Pubitemid 23100169)
31. Greenidge, P. A., Carlsson, B., Bladh, L. G. & Gillner, M. Pharmacophores incorporating numerous excluded volumes defined by X-ray crystallographic structure in three-dimensional database searching: application to the thyroid hormone receptor. J Med Chem 41, 2503-12 (1998). (Pubitemid 28321900)
32. Hamilton, G. S. & Steiner, J. P. Immunophilins: beyond immunosuppression. J Med Chem 41, 5119-43 (1998). (Pubitemid 29016306)
33. Wang, X. J. & Etzkorn, F. A. Peptidyl-prolyl isomerase inhibitors. Biopolymers 84, 125-46 (2006).
34. Bassat, Q. & Alonso, P. L. Defying malaria: Fathoming severe Plasmodium vivax disease. Nat Med 17, 48-9 (2011).
35. Carlton, J. M., Sina, B. J. & Adams, J. H. Why is Plasmodium vivax a neglected tropical disease? PLoS Negl Trop Dis 5, e1160 (2011).
36. Bohm, H. J. LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. J Comput Aided Mol Des 6, 593-606 (1992).
37. Kirchhoff, P. D., Brown, R., Kahn, S., Waldman, M. & Venkatachalam, C. M. Application of structure-based focusing to the estrogen receptor. Journal of Computational Chemistry 22, 993-1003 (2001). (Pubitemid 32614371)
38. Venkatachalam, C. M., Jiang, X., Oldfield, T. & Waldman, M. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J Mol Graph Model 21, 289-307 (2003). (Pubitemid 35441326)
39. Jones, G., Willett, P., Glen, R. C., Leach, A. R. & Taylor, R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267, 727-48 (1997). (Pubitemid 27170693)
40. Gehlhaar, D. K. et al. Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming. Chem Biol 2, 317-24 (1995).
41. Jain, A. N. Scoring noncovalent protein-ligand interactions: a continuous differentiable function tuned to compute binding affinities. J Comput Aided Mol Des 10, 427-40 (1996). (Pubitemid 126712439)
42. Muegge, I. PMF scoring revisited. J Med Chem 49, 5895-902 (2006). (Pubitemid 44484936)
43. Muegge, I. & Martin, Y. C. A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J Med Chem 42, 791-804 (1999). (Pubitemid 29136170)
44. Carta, G., Knox, A. J. & Lloyd, D. G. Unbiasing scoring functions: a new normalization and rescoring strategy. J Chem Inf Model 47, 1564-71 (2007). (Pubitemid 47210059)
45. Cheng, T., Li, X., Li, Y., Liu, Z. & Wang, R. Comparative assessment of scoring functions on a diverse test set. J Chem Inf Model 49, 1079-93 (2009).
46. Clark, R. D., Strizhev, A., Leonard, J. M., Blake, J. F. & Matthew, J. B. Consensus scoring for ligand/protein interactions. J Mol Graph Model 20, 281-95 (2002). (Pubitemid 34017546)
47. Oda, A., Tsuchida, K., Takakura, T., Yamaotsu, N. & Hirono, S. Comparison of consensus scoring strategies for evaluating computational models of proteinligand complexes. J Chem Inf Model 46, 380-91 (2006). (Pubitemid 43282129)
48. Teramoto, R. & Fukunishi, H. Supervised consensus scoring for docking and virtual screening. J Chem Inf Model 47, 526-34 (2007). (Pubitemid 46615954)
49. Wang, R., Lu, Y. & Wang, S. Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem 46, 2287-303 (2003). (Pubitemid 36637914)
50. Fischer, G., Bang, H. & Mech, C. Determination of enzymatic catalysis for the cistrans-isomerization of peptide binding in proline-containing peptides. Biomed Biochim Acta 43, 1101-11 (1984). (Pubitemid 15221717)
51. Harvey, M.& Christopoulos, A. Fitting Models to Biological Data using Linear and Nonlinear Regression. A Practical Guide to Curve Fitting (Oxford University Press, New York, New York, 2004).
52. Donella-Deana, A., Krinks, M. H., Ruzzene, M., Klee, C. & Pinna, L. A. Dephosphorylation of phosphopeptides by calcineurin (protein phosphatase 2B). Eur J Biochem 219, 109-17 (1994). (Pubitemid 24053623)
53. Enz, A., Shapiro, G., Chappuis, A. & Dattler, A. Nonradioactive assay for protein phosphatase 2B (calcineurin) activity using a partial sequence of the subunit of cAMP-dependent protein kinase as substrate. Anal Biochem 216, 147-53 (1994). (Pubitemid 24036844)
54. Harder, K. W. et al. Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides. Biochem J 298(Pt 2), 395-401 (1994). (Pubitemid 24072483)
55. Martin, B., Pallen, C. J., Wang, J. H. & Graves, D. J. Use of fluorinated tyrosine phosphates to probe the substrate specificity of the low molecular weight phosphatase activity of calcineurin. J Biol Chem 260, 14932-7 (1985). (Pubitemid 16188353)
56. Mondragon, A. et al.Overexpression and purification of human calcineurin alpha from Escherichia coli and assessment of catalytic functions of residues surrounding the binuclear metal center. Biochemistry 36, 4934-42 (1997). (Pubitemid 27180975)
57. Bosch, J. et al. Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase. J Med Chem 49, 5939-46 (2006). (Pubitemid 44484940)
58. Otwinowski, Z. & Minor, W. Processing of X-ray Diffraction Data Collected in Oscillation Mode. Methods in Enzymology 276, 307-326 (1997). (Pubitemid 27085611)
59. Pflugrath, J. W. The finer things in X-ray diffraction data collection. Acta Crystallogr D Biol Crystallogr 55, 1718-25 (1999). (Pubitemid 29504426)
60. McCoy, A. J. et al. Phaser crystallographic software. J Appl Crystallogr 40, 658-674 (2007). (Pubitemid 47080256)
61. Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr 67, 355-67 (2011).
62. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126-32 (2004). (Pubitemid 41742764)
63. Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66, 12-21 (2010).
64. Ramachandran, G. N., Ramakrishnan, C. & Sasisekharan, V. Stereochemistry of polypeptide chain configurations. J Mol Biol 7, 95-9 (1963).
65. DeLano, W. L. The PyMOL Molecular Graphics System. DeLano Scientific, Palo Alto, CA, USA (2002).